EUVIMEDEUVIMED entdecken
Crossref

The ALOX5 inhibitor Zileuton regulates tumor-associated macrophage M2 polarization by JAK/STAT and inhibits pancreatic cancer invasion and metastasis

Wei-Min Hu, Si-Qing Liu, Kong-Fan Zhu, Wei Li, Zhi-Jian Yang, Qiang Yang, Zhong-Chao Zhu, Jian Chang

International Immunopharmacology · 2023-08 · 121 · 110505

DOI: 10.1016/j.intimp.2023.110505 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2023-08. Verfasst von Wei-Min Hu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pancreatic Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, PR China. Hauptthemen laut MEDLINE: Tumor-Associated Macrophages, Pancreatic Neoplasms. Die Arbeit wurde bisher 67-mal zitiert (Crossref) und nennt 55 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

5-lipoxygenase (encoded by ALOX5) plays an important role in immune regulation. Zileuton is currently the only approved ALOX5 inhibitor. However, the mechanisms of ALOX5 and Zileuton in progression of pancreatic cancer remain unclear. Therefore, we investigated the effects of Zileuton on tumor-associated macrophage M2 polarization and pancreatic cancer invasion and metastasis, both in vivo and in vitro. In bulk RNA sequencing (RNA-seq) and single-cell RNA sequencing (scRNA-seq) analyses, we found a significant association between elevated levels of ALOX5 and poor survival, adverse stages, M2 macrophage infiltration, and the activation of JAK/STAT pathways in macrophages. In clinical samples, immunofluorescence, quantitative real-time PCR and immunohistochemical results verified the high expression of ALOX5 in pancreatic cancer, primarily in macrophages. We constructed PANC-1 human pancreatic cancer cells and macrophages overexpressing ALOX5 using lentivirus. In PANC-1 pancreatic cancer cells, low-dose Zileuton inhibited PANC-1 cell invasion and migration by blocking ALOX5. In macrophages, ALOX5 induced the M2-like phenotype through the JAK/STAT pathway and promoted the chemotaxis of macrophages towards PANC-1 cells, while Zileuton can inhibit these effects. We constructed the nude mouse model of in situ transplantation tumor of pancreatic cancer. After treatment with Zileuton, the mice showed increased survival rates and reduced liver metastasis. These findings indicate that ALOX5 regulates tumor-associated macrophage M2 polarization via the JAK/STAT pathway and promotes invasion and metastasis in pancreatic cancer. Zileuton can inhibit these effects by inhibiting ALOX5. These results provide a theoretical basis for the potential use of Zileuton in the treatment of pancreatic cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor-Associated MacrophagesPancreatic NeoplasmsHumansAnimalsMiceSignal TransductionJanus KinasesArachidonate 5-LipoxygenaseCell ProliferationSTAT Transcription FactorsCell Line, TumorHydroxyurea

Stichwörter der Autor:innen

5-LipoxygenaseJAK/STAT pathwayM2 macrophage polarizationPancreatic cancer

Substanzen

Janus KinasesArachidonate 5-LipoxygenaseSTAT Transcription FactorszileutonHydroxyureaALOX5 protein, human

Autor:innen und Institutionen

  • Department of Pancreatic Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, PR China.
  • Department of Pancreatic Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, PR China. Electronic address: zhuzhongchao@163.com.
  • Department of Pancreatic Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, PR China. Electronic address: Changjian1022@sina.com.

Zitieren

APA

Hu, W. M., Liu, S. Q., Zhu, K. F., Li, W., Yang, Z. J., Yang, Q., Zhu, Z. C., & Chang, J. (2023). The ALOX5 inhibitor Zileuton regulates tumor-associated macrophage M2 polarization by JAK/STAT and inhibits pancreatic cancer invasion and metastasis. International Immunopharmacology, 121, 110505. https://doi.org/10.1016/j.intimp.2023.110505

Vancouver

Hu WM, Liu SQ, Zhu KF, Li W, Yang ZJ, Yang Q, et al. The ALOX5 inhibitor Zileuton regulates tumor-associated macrophage M2 polarization by JAK/STAT and inhibits pancreatic cancer invasion and metastasis. International Immunopharmacology. 2023;121:110505. doi:10.1016/j.intimp.2023.110505

BibTeX
@article{Hu2023,
  author = {Hu, Wei-Min and Liu, Si-Qing and Zhu, Kong-Fan and Li, Wei and Yang, Zhi-Jian and Yang, Qiang and Zhu, Zhong-Chao and Chang, Jian},
  title = {The ALOX5 inhibitor Zileuton regulates tumor-associated macrophage M2 polarization by JAK/STAT and inhibits pancreatic cancer invasion and metastasis},
  journal = {International Immunopharmacology},
  year = {2023},
  volume = {121},
  pages = {110505},
  doi = {10.1016/j.intimp.2023.110505}
}
Kostenlos starten →